SCHEMBL26530451

SCHEMBL26530451

CC(F)c1nnc(-c2ccc(COc3ccc(CC#N)cc3)nc2)o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 11/20 0.42
HPGD P15428 4/20 0.38
LMNA P02545 2/20 0.38
GAA P10253 1/20 0.38
CASP3 P42574 1/20 0.38
HTT P42858 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC1 Q13547 1/20 0.35
NPC1 O15118 2/20 0.35
TSHR P16473 2/20 0.35
RAB9A P51151 2/20 0.35
HSD17B10 Q99714 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26529821 0.92 HDAC6 (0.48) HDAC6HPGDLMNAGAACASP3
SCHEMBL26530425 0.88 HDAC6 (0.45) HDAC6HPGDLMNAGAACASP3
SCHEMBL26530404 0.86 HDAC6 (0.46) HDAC6NPC1RAB9A
SCHEMBL26530439 0.85 HDAC6 (0.41) HDAC6HPGDLMNAGAACASP3
SCHEMBL26530397 0.85 HDAC6 (0.52) HDAC6HPGDLMNAGAACASP3
SCHEMBL26530409 0.84 KDM4E (0.46) HDAC6HPGDLMNAKDM4EALDH1A1
SCHEMBL26530499 0.82 HDAC6 (0.47) HDAC6HPGDKDM4EALDH1A1MAPT
SCHEMBL26530420 0.82 HDAC6 (0.46) HDAC6HPGDLMNAHTTALDH1A1
SCHEMBL26530454 0.82 HDAC6 (0.49) HDAC6HDAC1
SCHEMBL26530545 0.81 HDAC6 (0.43) HDAC6HPGDLMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322747-A1 OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF EIKONIZO THERAPEUTICS, INC. (US) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322747-A1 OXADIAZOLE HDAC6 INHIBITORS AND USES THEREOF HDAC6, HDAC1, HDAC11 HDAC6 1/4885HPGD 1372/4885LMNA 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.